Validation of the Psychiatric Diagnostic Screening Questionnaire (PDSQ) in a Spanish sample of alcoholic patients
DOI:
https://doi.org/10.20882/adicciones.180Keywords:
alcoholism, dual diagnosis, mental disorders, psychometric properties, questionnairesAbstract
Objective: This study evaluates the psychometric properties of the Psychiatric Diagnostic Screening Questionnaire (PDSQ) in alcohol-dependent Spanish population as a means of detecting psychiatric comorbidity. Methods: The PDSQ (Zimmerman, 2001) is a self-administered questionnaire with 125 items which can be applied in just 15 minutes, enabling rapid and effective screening of the psychiatric disorders (Axis I) most commonly found among substance abusers. After linguistic adaptation (translation/back-translation) and verification of its content validity, the PDSQ was administered to 156 alcohol-dependent patients (DSM-IV criteria; women = 36%), treated consecutively in an alcohol-disorders treatment setting. Its psychometric properties (reliability and validity) were determined, applying the DSM-IV criteria as a “gold standard”, by means of SCID interview. Results: Using the original cut-off points, the PDSQ showed excellent internal reliability (α = 0.68-0.96) and diagnostic validity, with mean sensitivity = 99.6% (range: 96.6%-100%), specificity = 69.5% (range: 51.9%- 94.6%) and NPV = 99.8% (range: 98.6%-100%). Diagnostic efficiency with the original cut-off points was 73.2%, rising to 91.6% using new cut-off points for certain scales, with a degree of agreement with DSM-IV criteria of κ = .303 -. 896. Conclusions: The PDSQ is a reliable and valid instrument for detecting psychiatric comorbidity in alcoholic individuals. Its psychometric properties and the added value of self-administration and short application time make it a recommended instrument for use in routine clinical settings.References
Asociación Española de Patología Dual. Estudio epidemiológico para determinar la prevalencia, diagnóstico y actitud terapéutica de la patología dual en la Comunidad de Madrid. Madrid; 2008.
Gual A. Dual diagnosis in Spain. Drug Alcohol Rev 2007; 26: 65-71.
Torrens M, Martín-Santos R, Samet S. Importance of clinical diagnoses for comorbidity studies in substance use disorders. Neurotox Res 2006; 10: 253-61.
Torrens M, Serrano D, Astals M, Pérez-Domínguez G, Martín-Santos R. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am J Psychiatry 2004; 161: 1231-7.
Ferrando L, Bobes J, Gibert J, Soto M, Soto O. Mini-International Neuropsychiatric Interview. Versión en Español 5.0.0. 2005. Disponible en: https://www.medical-outcomes.com/HTMLFiles/MINI/MINI.htm [consultado el 21/11/09].
Roca M, Martín-Santos R, Sáiz J, Obiols J, Serrano MJ, Torrens M et al. Diagnostic Interview for Genetic Studies (DIGS): inter-rater and test-retest reliability and validity in a Spanish population. Eur Psychiatry 2007; 22: 44-8.
Zimmerman M, Mattia JI. The reliability and validity of a screening Questionnaire for 13 DSM-IV Axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. J Clin Psychiatry 1999; 60: 677–83.
Zimmerman M. The Psychiatric Diagnostic Screening Questionnaire manual. Los Angeles (CA): Western Psychological Services; 2002.
Zimmerman M, Mattia JI. A Self-Report Scale to Help Make Psychiatric Diagnoses: The Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry 2001; 58: 787-94.
Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
Zimmerman M, Mattia JI. The Psychiatric Diagnostic Screening Questionnaire: Development, reliability and validity. Compr Psychiatry 2001; 42: 175-89.
Rush B, Zaslavska N, Veldhuizen S. A Comparison of alternative approaches for screening for substance abuse in two community mental health services. Toronto: Centre for Addiction and Mental Health. Health Systems Research & Consulting Unit; 2005.
Magruder KM, Sonne SC, Brady KT, Quello S, Martin RH. Screening for co-occurring mental disorders in drug treatment populations. J Drug Issues 2005; 35: 593-605.
Castel S, Rush B, Kennedy S, Fulton K, Toneatto T. Screening for mental health problems among patients with substance use disorders: preliminary findings on the validation of a selfassessment instrument. Can J Psychiatry 2007; 52: 22-7.
Zimmerman M, Sheeran T, Chelminski I, Young D, Screening for
psychiatric disorders in outpatients with DSM-IV substance use disorders. J Subst Abuse Treat 2004; 26: 181-8.
Rush AJ, Zimmerman M, Wisniewski SR, Fava M, Hollon SD, Warden D et al. Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features. J Affect Disord 2005; 87: 43–55.
Fava M, Rush AJ, Alpert JE, Carmin CN, Balasubramani GK, Wisniewski SR et al. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry 2006; 51: 823-35.
Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M et al. Concurrent anxiety and substance use disorders among outpatients with major depression: Clinical features and effect on treatment outcome. Drug Alcohol Depend 2009; 99:248–60.
